Abstract Number: PO0057
Meeting: ISTH 2022 Congress
Background: The antiphospholipid syndrome is an autoimmune, prothrombotic and systemic disorder characterized by arterial and/or venous thrombosis, recurrent fetal loss and persistently elevated antiphospholipid antibody titers.
Aims: To identify the various forms of manifestation of antiphospholipid syndrome
Methods: A retrospective, longitudinal and descriptive study in which the cases of arterial and venous thrombosis associated with thrombophilia
type antiphospholipid syndrome presented during the period from 2016 to 2018 in a Hospital of Veracruz, Mexico were analyzed.
Results: We found 7 patients with venous and arterial thrombotic symptoms that were studied antiphospholipid syndrome, the most affected gender was the female and the predominant age group was 21-30 years. The thrombotic event with the highest incidence was in the deep venous system of the pelvic extremities in 5 patients, in one case it was observed as a complication associated with pulmonary thromboembolism and in another case acute cerebral infarction. The antiphospholipid syndrome was primary in 6 cases and one associated with systemic lupus erythematosus
Conclusion(s): The clinical spectrum of antiphospholipid syndrome is diverse and must be taken into account in order to establish an effective diagnosis and treatment.
To cite this abstract in AMA style:Del Carpio-Orantes L, García-Méndez S, Sánchez-Díaz J, Rosas-Lozano A. Clinical spectrum of antiphospholipid syndrome in a second level general hospital. [abstract]. https://abstracts.isth.org/abstract/clinical-spectrum-of-antiphospholipid-syndrome-in-a-second-level-general-hospital/. Accessed October 1, 2023.
« Back to ISTH 2022 Congress
ISTH Congress Abstracts - https://abstracts.isth.org/abstract/clinical-spectrum-of-antiphospholipid-syndrome-in-a-second-level-general-hospital/